Who owns Kura Oncology, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of KURA from SEC Form 13F filings across 221 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 221 institutions disclosed 86.9M shares of Kura Oncology, Inc. worth $953.1M — about 97.9% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
221
13F holders
$953.1M
value, 2026 filers
97.9%
of shares outstanding (86.9M sh)
32
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of KURA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.5M | $115.3M | 0.0% | 11.8% | +9.0% |
| 2 | MONTANOVA CAPITAL, LLC | 8.6M | $94.1M | 1.7% | 9.7% | 0.0% |
| 3 | BVF INC/IL | 8.4M | $92.7M | 2.4% | 9.5% | 0.0% |
| 4 | STATE STREET CORP | 5.3M | $58.5M | 0.0% | 6% | +18.1% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 3.9M | $43.0M | 0.0% | 4.4% | +3.4% |
| 6 | ARMISTICE CAPITAL, LLC | 3.7M | $40.3M | 0.5% | 4.1% | -1.6% |
| 7 | AQR CAPITAL MANAGEMENT LLC | 3.1M | $34.3M | 0.0% | 3.5% | +47.2% |
| 8 | GOLDMAN SACHS GROUP INC | 2.3M | $24.8M | 0.0% | 2.5% | +58.0% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.2M | $24.5M | 0.0% | 2.5% | +9.6% |
| 10 | ALETHEA CAPITAL MANAGEMENT, LLC | 2.2M | $23.8M | 9.9% | 2.4% | +41.8% |
| 11 | Prosight Management, LP | 2.0M | $22.2M | 3.8% | 2.3% | -39.8% |
| 12 | Deep Track Capital, LP | 2.0M | $21.7M | 0.3% | 2.2% | -25.2% |
| 13 | RENAISSANCE TECHNOLOGIES LLC | 1.7M | $18.3M | 0.0% | 1.9% | +5.1% |
| 14 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIPNEW | 1.4M | $15.5M | 0.0% | 1.6% | new |
| 15 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3M | $14.6M | 0.0% | 1.5% | +8.1% |
| 16 | NAN FUNG TRINITY (HK) LTD | 1.2M | $12.9M | 1.3% | 1.3% | +10.3% |
| 17 | Qube Research & Technologies Ltd | 1.2M | $12.8M | 0.0% | 1.3% | -28.5% |
| 18 | DIMENSIONAL FUND ADVISORS LP | 1.2M | $12.8M | 0.0% | 1.3% | -18.0% |
| 19 | BANK OF AMERICA CORP /DE/ | 1.2M | $12.7M | 0.0% | 1.3% | -5.6% |
| 20 | MORGAN STANLEY | 1.2M | $12.7M | 0.0% | 1.3% | -0.3% |
| 21 | Connor, Clark & Lunn Investment Management Ltd. | 996,114 | $10.9M | 0.0% | 1.1% | +24.4% |
| 22 | UBS Group AG | 964,636 | $10.6M | 0.0% | 1.1% | -7.3% |
| 23 | JACOBS LEVY EQUITY MANAGEMENT, INC | 948,974 | $10.4M | 0.0% | 1.1% | +57.6% |
| 24 | NORTHERN TRUST CORP | 831,160 | $9.1M | 0.0% | 0.9% | +9.9% |
| 25 | MILLENNIUM MANAGEMENT LLC | 711,332 | $7.8M | 0.0% | 0.8% | -54.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.